Education
2002 Johns Hopkins University BME BS
2004 Columbia University BME MS
2009 KAIST Biological Sciences PhD
Research Field
RNA based gene and cell therapy
Representative Publication
- Innate immune responses against mRNA vaccine promote cellular immunity through IFN-β at the injection site. Nature Communications. 2024
- In vivo genome editing using 244-cis LNPs and low-dose AAV achieves therapeutic threshold in hemophilia A mice. Molecular Therapy Nucleic Acids. 2023
- Lipid nanoparticles (LNPs) for in vivo RNA delivery and their breakthrough technology for future applications. Advanced Drug Delivery Reviews. 2023
- Engineered Lipid Nanoparticles for the Treatment of Pulmonary Fibrosis by Regulating Epithelial-Mesenchymal Transition in the Lungs. Adv. Funct. Mater. 2022
- Engineered ionizable lipid nanoparticles for targeted delivery of RNA therapeutics into different types of cells in the liver. Science Adv. 2021
